Form D · Other Technology
SemiosBio Technologies Inc.
Vancouver, A1 · CIK 0001665916
Offering snapshot reported Oct 19, 2017 · SEC filing
- Reported sold
- $79.9K Offering amount: $79.9K
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 6, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 19, 2017 | Initial | $79,895 | No comparison | 5 | SEC filing |
| Nov 28, 2016 | Initial | $54,384 | No comparison | 4 | SEC filing |
| Feb 8, 2016 | Initial | $114,708 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-297082
Cdn$1.2549=US$1.00
Class A Voting Common Shares
Source: Form D, filed Oct 19, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Reid Carter | Director |
| Michael Gilbert | Director, Executive |
| Jack Gin | Director |
| Malcolm Kendall | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
101 887 Great Northern Way
Vancouver, A1, V5T 4T5
Vancouver, A1, V5T 4T5